YIH
ALDX icon

Y-Intercept (HK)’s Aldeyra Therapeutics ALDX Stock Holding History

Y-Intercept (HK)’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4K Buy
+17,084
New +$29.4K ﹤0.01% 1630
2025
Q4 		– Sell
-138,091
Closed -$721K – 1500
2025
Q3 		$721K Buy
+138,091
New +$720K 0.02% 1119
2024
Q1 		– Sell
-25,354
Closed -$89K – 1326
2023
Q4 		$89K Buy
+25,354
New +$78.2K 0.01% 1108

Other funds holding ALDX

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Y-Intercept (HK)'s ALDX Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 17,084 shares worth $36.4K. The stake represents ﹤0.01% of the portfolio and ranks #1630 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ALDX as recently as Q3 2025.

Y-Intercept (HK) first reported a position in ALDX in Q4 2023 and has held it in 3 quarters since. The position peaked at $721K in Q3 2025. 18 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Y-Intercept (HK) held 17,084 shares of Aldeyra Therapeutics worth $36.4K as of Q2 2026.
  • Aldeyra Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1630 holding.
  • Y-Intercept (HK) first reported a position in Aldeyra Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Aldeyra Therapeutics position peaked at $721K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.